Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure

Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure

Conclusion HFNT use is associated with a reduction in the rate of invasive mechanical ventilation and overall mortality in patients with COVID-19 infection.

Bibliographic Details
Main Authors: Rohit Gupta, Andrew Gangemi, Huaqing Zhao, Maulin Patel, Robert Marron, Junad Chowdhury, Ibraheem Yousef, Matthew Zheng, Nicole Mills, Lauren Tragesser, Julie Giurintano, Matthew Gordon, Parth Rali, Gilbert D'Alonso, Nicole Patlakh
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/7/1/e000650.full

Internet

https://bmjopenrespres.bmj.com/content/7/1/e000650.full

Similar Items